11 Patents
- 0 cites
- US122330592025Effective Treatment of Depression in Patients Having Impaired Learning And/or Memory or Certain EEG Characteristics with a Benzylpiperazine-aminopyridine Agent
Alto Neuroscience, Inc.
0 cites - US122263752025Method of Treatment and Selection of Patients Benefiting from Agomelatine Based on EEG Measurements
ALTO NEUROSCIENCE, Inc.
0 cites - US122080962025Effective Treatment of Depression in Patients Having Impaired Learning And/or Memory or Certain EEG Characteristics with a Benzylpiperazine-aminopyridine Agent
ALTO NEUROSCIENCE, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US117235692023Methods of Identifying Schizophrenia Patients at Risk for Relapse
JANSSEN PHARMACEUTICA NV
0 cites